From Trousseau to targeted therapy: new insights and innovations in thrombosis and cancer.
about
Parenteral anticoagulation in ambulatory patients with cancerOral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulationAnticoagulation for the long-term treatment of venous thromboembolism in patients with cancerOral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulationParenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulationParenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulationOral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulationOral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulationAnticoagulation for the long-term treatment of venous thromboembolism in patients with cancerErythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient dataErythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient dataAnticoagulation for the long term treatment of venous thromboembolism in patients with cancerArterial and venous thrombosis in cancer patientsParenteral anticoagulation may prolong the survival of patients with limited small cell lung cancer: a Cochrane systematic review.Common risk factors for both arterial and venous thrombosis.The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants.Hypercoagulable state, pathophysiology, classification and epidemiology.Clinical significance of the ratio between the alpha 2 plasmin inhibitor-plasmin complex and the thrombin-antithrombin complex in advanced non-small cell lung cancer.A rare cause of chest pain in a cancer patient.Enhanced antithrombotic effects of unfractionated heparin in rats after repeated oral doses and its relationship to endothelial heparin concentration.Do thrombophilic gene mutations have a role on thromboembolic events in cancer patients?Risk of prostate cancer death in long-term users of warfarin: a population-based case-control study.Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation.Parenteral anticoagulation in ambulatory patients with cancer.
P2860
Q22252972-71AFFA59-93F1-4CC0-B29F-B526D40C1D61Q24194116-336BBBD0-447D-4B9D-8F59-4287B5FA5A16Q24194904-7C8971DF-C879-4F68-99ED-22835801883AQ24194926-E5337AAF-4FD6-45D5-835A-F10254AD20D3Q24234857-3796B217-750A-481A-B3C1-18E7B0C2DBAEQ24235112-47AA38D8-5CC9-4776-BC79-2F09C8A4427AQ24235785-9D0C82C8-EC22-446D-9B9C-2AE764C82B5AQ24236595-6C633FD2-9439-457A-85A9-DA0B7E966B17Q24236620-A5A21F20-A348-4B88-B38A-93CDF3998F2AQ24240202-D738B1C6-8E99-4AB5-8E0D-97533F9E5626Q24242864-1EA1CE28-0F7D-4CE9-88A3-C8C3240554CBQ24243286-8DF70A4E-902C-4BF3-BB52-58E044E85DA7Q34635182-56586F61-FD28-4EC9-8418-B83BEDA02EFEQ36734996-EB1C2082-1E63-4B55-8BE5-BB5BAEDBE951Q37084853-0E8EE8FF-0793-44C8-ACB1-0D7A9A3C1FBFQ37316352-49C438AF-6D84-48E6-BC2C-A41831F2FB9EQ37809540-3A855DA8-2C13-4DC6-A62F-59834FE5EE76Q39890449-A1CE50DB-FB54-47E7-8766-6E8C73051200Q42852290-300EC36F-06C3-46F0-A841-8F0775384F0AQ43088071-3EF5DA40-1395-475B-9C3B-09FA6A3059ADQ44200568-2A8DC2F8-C14C-4E1F-86E3-7D99412EC0EEQ44665233-B89F1BDD-A00E-4B9C-9ABD-02547452023CQ47235947-684A19F2-11F7-4198-A842-669214839903Q47551857-06A6AF23-4061-4790-AB73-A1E367F2158E
P2860
From Trousseau to targeted therapy: new insights and innovations in thrombosis and cancer.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
From Trousseau to targeted the ...... ions in thrombosis and cancer.
@ast
From Trousseau to targeted the ...... ions in thrombosis and cancer.
@en
type
label
From Trousseau to targeted the ...... ions in thrombosis and cancer.
@ast
From Trousseau to targeted the ...... ions in thrombosis and cancer.
@en
prefLabel
From Trousseau to targeted the ...... ions in thrombosis and cancer.
@ast
From Trousseau to targeted the ...... ions in thrombosis and cancer.
@en
P2093
P2860
P1476
From Trousseau to targeted the ...... ions in thrombosis and cancer.
@en
P2093
P2860
P304
P356
10.1046/J.1538-7836.2003.00275.X
P577
2003-07-01T00:00:00Z